86 related articles for article (PubMed ID: 9387517)
21. Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines.
Wilson KE; Bartlett JM; Miller EP; Smyth JF; Mullen P; Miller WR; Langdon SP
Br J Cancer; 1999 May; 80(5-6):685-92. PubMed ID: 10360644
[TBL] [Abstract][Full Text] [Related]
22. The role of transforming growth factor alpha in determining growth factor independence.
Awwad RA; Sergina N; Yang H; Ziober B; Willson JK; Zborowska E; Humphrey LE; Fan R; Ko TC; Brattain MG; Howell GM
Cancer Res; 2003 Aug; 63(15):4731-8. PubMed ID: 12907656
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor (EGF) receptor density controls mitogenic activation of normal rat kidney (NRK) cells by EGF.
Lahaye DH; Camps MG; Erp PE; Peters PH; Zoelen EJ
J Cell Physiol; 1998 Jan; 174(1):9-17. PubMed ID: 9397151
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of transforming growth factor alpha (TGF-alpha)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868.
Simpson BJ; Bartlett JM; Macleod KG; Rabiasz G; Miller EP; Rae AL; Gordge P; Leake RE; Miller WR; Smyth J; Langdon SP
Br J Cancer; 1999 Mar; 79(7-8):1098-103. PubMed ID: 10098742
[TBL] [Abstract][Full Text] [Related]
25. Protein kinase A-Ialpha subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway.
Alper O; Hacker NF; Cho-Chung YS
Oncogene; 1999 Sep; 18(35):4999-5004. PubMed ID: 10490835
[TBL] [Abstract][Full Text] [Related]
26. Osteoblast-derived growth factors enhance adriamycin-cytostasis of MCF-7 human breast cancer cells.
Choki I; Sourla A; Reyes-Moreno C; Koutsilieris M
Anticancer Res; 1998; 18(6A):4213-24. PubMed ID: 9891470
[TBL] [Abstract][Full Text] [Related]
27. The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-beta in endometrial carcinoma.
Ripley D; Tang XM; Ma C; Chegini N
Gynecol Oncol; 2001 May; 81(2):301-9. PubMed ID: 11330966
[TBL] [Abstract][Full Text] [Related]
28. Antagonistic growth regulation of cell lines derived from human lung adenocarcinomas of Clara cell and aveolar type II cell lineage: Implications for chemoprevention.
Adissu HA; Schuller HM
Int J Oncol; 2004 Jun; 24(6):1467-72. PubMed ID: 15138589
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
Guo Y; Kyprianou N
Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
[TBL] [Abstract][Full Text] [Related]
30. [Effects of growth factors and estrogen on the proliferation and prolactin gene expression in anterior pituitary cells of rats].
Wu X; Zhang R; Di A; Shan H; Xu R
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Oct; 21(5):331-7. PubMed ID: 12567429
[TBL] [Abstract][Full Text] [Related]
31. Pentoxifylline inhibits PDGF-induced proliferation of and TGF-beta-stimulated collagen synthesis by vascular smooth muscle cells.
Chen YM; Wu KD; Tsai TJ; Hsieh BS
J Mol Cell Cardiol; 1999 Apr; 31(4):773-83. PubMed ID: 10329205
[TBL] [Abstract][Full Text] [Related]
32. The role of peptide growth factors in epithelial ovarian cancer.
Berchuck A; Olt GJ; Everitt L; Soisson AP; Bast RC; Boyer CM
Obstet Gynecol; 1990 Feb; 75(2):255-62. PubMed ID: 2300354
[TBL] [Abstract][Full Text] [Related]
33. Up-regulation of vascular endothelial growth factor-C by nicotine in cervical cancer cell lines.
Lane D; Gray EA; Mathur RS; Mathur SP
Am J Reprod Immunol; 2005 Mar; 53(3):153-8. PubMed ID: 15727570
[TBL] [Abstract][Full Text] [Related]
34. Growth regulation of ovarian cancer cells by epidermal growth factor and transforming growth factors alpha and beta 1.
Zhou L; Leung BS
Biochim Biophys Acta; 1992 Dec; 1180(2):130-6. PubMed ID: 1463764
[TBL] [Abstract][Full Text] [Related]
35. The role for transforming growth factor-beta (TGF-beta) in human cancer.
Gold LI
Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
[TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
Putz T; Culig Z; Eder IE; Nessler-Menardi C; Bartsch G; Grunicke H; Uberall F; Klocker H
Cancer Res; 1999 Jan; 59(1):227-33. PubMed ID: 9892211
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells.
Evangelou A; Jindal SK; Brown TJ; Letarte M
Cancer Res; 2000 Feb; 60(4):929-35. PubMed ID: 10706107
[TBL] [Abstract][Full Text] [Related]
38. Growth factors and apoptosis in development. The role of insulin like growth factor I and TGFbeta1 in regulating cell growth and cell death in a human teratocarcinoma derived cell line.
Granerus M; Schofield P; Bierke P; Engström W
Int J Dev Biol; 1995 Oct; 39(5):759-64. PubMed ID: 8645559
[TBL] [Abstract][Full Text] [Related]
39. Essential role for G proteins in prostate cancer cell growth and signaling.
Kue PF; Daaka Y
J Urol; 2000 Dec; 164(6):2162-7. PubMed ID: 11061948
[TBL] [Abstract][Full Text] [Related]
40. Potential role of growth factors in ovarian cancer.
Jassoni VM; Amadori A; Gentile G; Alesi L
Front Biosci; 1996 Dec; 1():g14-9. PubMed ID: 9159261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
